SCHEMBL14213261

SCHEMBL14213261

CCOC(=O)COc1c(C)cccc1Cc1cccc(Cc2cccc(Cc3cccc(C)c3O)c2OCC(=O)OCC)c1O

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NLRP3 Q96P20 6/20 0.45
KDM4E B2RXH2 1/20 0.40
ALDH1A1 P00352 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
CASP3 P42574 1/20 0.40
CASP7 P55210 1/20 0.40
CASP9 P55211 1/20 0.40
KMT2A Q03164 2/20 0.39
HTT P42858 1/20 0.39
HPGD P15428 1/20 0.39
USP2 O75604 2/20 0.39
HSD17B10 Q99714 1/20 0.39
ATM Q13315 1/20 0.39
GAA P10253 1/20 0.38
NPSR1 Q6W5P4 1/20 0.38
PPARG P37231 1/20 0.38
PPARA Q07869 1/20 0.38
GABRA1 P14867 1/20 0.37
GABRB2 P47870 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13992521 0.94 NLRP3 (0.49) NLRP3KDM4EALDH1A1SMN1; SMN2L3MBTL1
SCHEMBL10046762 0.82 CASP3 (0.46) NLRP3KDM4EALDH1A1SMN1; SMN2CASP3
SCHEMBL2058956 0.80 NLRP3 (0.57) NLRP3KDM4EALDH1A1SMN1; SMN2L3MBTL1
SCHEMBL16501698 0.79 GABRA1 (0.46) NLRP3ALDH1A1SMN1; SMN2L3MBTL1KMT2A
SCHEMBL14193732 0.79 USP2 (0.52) NLRP3KDM4EALDH1A1SMN1; SMN2CASP3
SCHEMBL14213249 0.78 GABRA1 (0.45) NLRP3KDM4EALDH1A1SMN1; SMN2L3MBTL1
SCHEMBL10046745 0.76 GABRA1 (0.46) NLRP3KDM4EALDH1A1SMN1; SMN2L3MBTL1
SCHEMBL14213260 0.75 ALDH1A1 (0.35) KDM4EALDH1A1KMT2AHTTGABRA1
SCHEMBL29853174 0.74 PKM (0.51) NLRP3KDM4EALDH1A1KMT2AHTT
SCHEMBL21438124 0.74 PKM (0.51) NLRP3KDM4EALDH1A1KMT2AHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8716343-B2 Calixarene-based peptide conformation mimetics, methods of use, and methods of making REGENTS OF THE UNIVERSITY OF MINNESOTA (US) 2014-05-06 US disclosed
US-20120309801-A1 CALIXARENE-BASED PEPTIDE CONFORMATION MIMETICS, METHODS OF USE, AND METHODS OF MAKING REGENTS OF THE UNIVERSITY OF MINNESOTA (US) 2012-12-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120309801-A1 CALIXARENE-BASED PEPTIDE CONFORMATION MIMETICS, METHODS OF USE, AND METHODS OF MAKING CLSPN, BID, CALU NLRP3 4081/4885KDM4E 4750/4885ALDH1A1 4794/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.